In this edition
- Introducing HighPlex Ascend
- Extraction-Free and Pre-Extraction workflows
- New testing solutions for Vector-Borne Disease
- Improvements to our Gastrointestinal panels
- Meet our new team member
- Reflecting on industry trends
- Company cultural highlights
- We’re hiring!
- Join a network of diagnostics professionals
Introducing HighPlex AscendOur team has been working diligently to bring you the next generation of low to medium-throughput PCR automation. Featuring a sleek new profile, the transparent lid allows for status-checking at a glance from across the lab. The narrower footprint allows for more space for other laboratory processes to take place comfortably. The HighPlex Ascend is not just a facelift; it’s a product developed entirely by AusDiagnostics, designed from scratch using Australian technology and expertise. This product, while developed in-house, is also available for OEM projects to complement customised multiplex panels, offering a unique blend of local innovation and universal applicability with MT-PCR technology. Customers can be assured that they will benefit from a reliable, integrated supply chain with reduced manufacturing time, thanks to the seamless alignment of design, manufacturing, and logistics. The new design consists of fewer parts than its predecessor, making it not only a more sustainable product but also more reliable. Fewer parts mean simplified maintenance and enhanced manufacturing scalability, ensuring that the HighPlex Ascend meets the demands of a modern laboratory environment efficiently. Enquire now to be notified when stock becomes available for purchase.
|
Extraction-Free and Pre-Extraction workflowsLast year we introduced our Prepyx® category, featuring powerful sample preparation buffers to accelerate your diagnostics workflow. The AusDiagnostics teams have been working closely with customers to develop and refine our newest buffer. Prepyx® Tissue Digestion Buffer liberates hard-to-access dermatophytes and other fungi that are embedded within hair, skin, and nail specimens. Treating keratinous tissue samples with Prepyx® allows for vastly improved access to the pathogens of interest, preparing them for downstream sample extraction for better nucleic acid yields.
The new buffer joins Prepyx® Stool Extraction-Free Buffer in our sample preparation portfolio. Prepyx® Stool Extraction-Free Buffer simplifies and accelerates your diagnostics testing of gastrointestinal targets by eliminating the need for lengthy extraction protocols. Prepyx® Stool Extraction-Free Buffer is currently available for performance studies. Enquire now to be notified when stock is available for purchase.
|
New testing solutions for Vector-Borne DiseasesEEEEEEEEEEEEEEEEEEEEEE… It’s the unmistakable sound of the mosquito which is sadly synonymous with the dreaded fear of contracting one of several debilitating tropical diseases. Many of these infections thrive in underserved communities across Australia and Asia, often lacking mainstream industry support for molecular diagnostics. We are thrilled to introduce our new Vector-Borne Disease portfolio, targeting neglected tropical diseases spread by mosquitoes and other vectors.
Our support for diagnostics of neglected tropical diseases is aimed to support the United Nations’ sustainable development goals, ensuring targeted and relevant efforts to improve health equitably. This project is the result of collaboration with laboratories serving rural Australian communities whose experience was instrumental in shaping relevant, useful, and localised diagnostics. The Vector-Borne Disease portfolio supports our Tailored-Panels Initiative, in which the traditional one-size fits-all approach to diagnostics is relegated in favour of localising and customising diagnostics to cater to the precise needs of a given region. Through considerate co-creation with local stakeholders, laboratories, government bodies, and non-governmental organisations, a range of underserved healthcare priorities can tangibly benefit from a blend of scientific expertise and regional insights.
|
Improvements to our Gastrointestinal panelsWe are committed to continuously improving our products and services based on user feedback. As a result of careful post-market surveillance, we are thrilled to share several upcoming improvements to our range of Gastrointestinal TandemPlex® panels. The product changes were communicated to existing customers in a detailed advisory notice, and will improve the specificity, genotype inclusivity, non‑specific background amplification, robustness, and stability of certain assays. Seemingly every newsletter we publish includes an extensive list of product updates. Behind each list lies an enormous effort by our Research & Development, Quality Assurance, and Product Management teams to understand the plight of our customers and translate their challenges into tangible improvements. We would like to thank our customers for your continued support and collaboration in improving our panels and uplifting patient outcomes.
|
Meet our new team member
We are thrilled to welcome and introduce Carmine Rohan to the AusDiagnostics community.
|
Reflecting on industry trendsDiagnostics innovation starts with listening to our community. Our team recently met with the industry at the ESCMID Global 2024 conference in Spain, the ASM 2024 conference in the USA, and the ASM 2024 conference in Australia. These events are important opportunities to learn about the emerging challenges of our customers and users, and open a dialogue about what AusDiagnostics should aim to achieve. Here is what you said. “Who is R-Biopharm AG and why do you exhibit together?” In 2022, AusDiagnostics proudly joined the R-Biopharm AG family. The R-Biopharm AG group are a leading biotechnology company. The alliance has allowed us to accelerate the pace of our mission to improve patient health through worldwide distribution of innovative molecular diagnostic solutions and extend our support network to continue to deliver the best customer care. “Can you explain extraction-free testing for gastrointestinal targets?” We were thrilled with the response to our Prepyx® range, leading many to enquire about the Prepyx® Stool Extraction-Free Buffer. We designed Prepyx® Stool Extraction-Free Buffer to address the need for a highly expeditious method to substitute extraction that still delivers a quality, PCR-ready sample. Ideal for improving throughput, Prepyx® integrates seamlessly into your PCR workflow to simplify diagnostic testing. “Could you tell us about your diagnostics for urinary tract infections?” Our TandemPlex® panels utilise a patented process called multiplex-tandem PCR (MT-PCR) to reduce competitive binding. This enables simultaneous detection of targets of difference concentrations. Our UTI offering includes targets for bacteria, fungi, and antimicrobial resistance markers. These targets are arranged into panels consisting of clinically-relevant combinations for efficient screening, enabling clinicians to make rapid, informed decisions.
Join us at upcoming events
|
Company Culture HighlightsHarmony Day celebrates diversity, aiming to foster inclusiveness, respect, and the idea that people of all different cultures can make a valuable contribution to society. At AusDiagnostics, we don’t just celebrate diversity; we actively cultivate an inclusive culture. We believe that our diverse workforce fuels our innovation and drives our unique ideas and continual growth. As a company, we celebrated Harmony Day a week later so our colleagues observing Ramadan could attend the culturally diverse lunch.
|
We’re hiring!Our workplace is a melting pot of talents and personalities from around the globe. When you join our company, you join a network of passionate experts who enjoy a culture of mentorship and collaboration. We are currently hiring for a Senior IT Support Analyst role and a Recruitment Consultant.
|
Join a network of diagnostics professionalsOur social media community is a unique blend of professionals from clinical and non-clinical backgrounds. Following AusDiagnostics on social media is the perfect way to connect with an up-to-date network of peers to discuss the latest updates in the diagnostics world.
In case you missed it, here is a taste of our recent updates from Linkedin.
|
| Be the first to receive AusDiagnostics updates: |
Join the conversation:
    ↑ Back to top |
